Novo Nordisk Threatens Lawsuit Over Cheap Hims Copy of Wegovy Pill

Novo Nordisk is planning legal and regulatory action against telehealth provider Hims & Hers after they announced it would sell a lower cost weight-loss pill.

Feb 5, 2026, 10:32 PM

More Videos

Who Really Controls TikTok Now? Inside the U.S. Spin-Off

As TikTok announces a major U.S. spin-off, Kerry Flynn, Media Reporter at Axios, breaks down the deal, the timing, and what it means for tech policy.

Luxury Presence and the New Playbook for Modern Real Estate Agents

As real estate is reshaped by AI and affordability pressures, Malte Kramer, CEO and Founder of Luxury Presence, explains how agents adapt, scale, and win.

Josh D’Amaro Steps in as Disney CEO Amid Intensifying Streaming Battles

As streaming consolidation intensifies, Seth Schachner, Managing Director at StratAmericas, weighs in on Disney’s strategy under new CEO Josh D’Amaro.

Geopolitics, Trade, and Technology: The New Global Economic Order

Global markets hit a turning point as Michael Spence, Nobel Prize–winning economist and Professor Emeritus at Stanford University, assesses risks and growth.

From Check-In to Dinner: Airbnb Brings Celebrity Chefs to Your Stay

Airbnb teams up with CookUnity to deliver chef-prepared meals to rentals, blending hotel-style convenience with the comfort of cooking at home.

The Next Space Race: York Space Systems and the IPO Bet on American Orbital Power

Space investing heats up as York Space Systems CEO Dirk Wallinger discusses satellites, defense demand, and the company’s planned $4.25B IPO.

Go Fund Yourself: Focus Better, Sip Smarter

DOSE is an ADHD-friendly productivity app. Plus, Beyond Bottleshop is redefining premium beverage experiences online.

Markets React to Fed Decision, What Happens Next?

Fed’s latest rate decision shakes markets; Nathan Sheets of Citigroup breaks down impacts on growth, inflation, labor, investor sentiment, and policy risks.